Vitamin E: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Caesar Schinas mNo edit summary |
||
| Line 1: | Line 1: | ||
{{ | {{:Vitamin E/Cambridge Heart Antioxidant Study}} | ||
In [[biochemistry]], '''vitamin E''' is a "generic descriptor for all [[tocopherol]]s and [[tocotrienol]]s that exhibit [[alpha-tocopherol]] activity. by virtue of the phenolic hydrogen on the 2h-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of [[antioxidant]] activity, depending on the site and number of methyl groups and the type of [[isoprenoid]]s."<ref>{{MeSH}}</ref> | In [[biochemistry]], '''vitamin E''' is a "generic descriptor for all [[tocopherol]]s and [[tocotrienol]]s that exhibit [[alpha-tocopherol]] activity. by virtue of the phenolic hydrogen on the 2h-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of [[antioxidant]] activity, depending on the site and number of methyl groups and the type of [[isoprenoid]]s."<ref>{{MeSH}}</ref> | ||
Revision as of 01:42, 23 May 2009
| Nonfatal MI | |
|---|---|
| Vitamin E 800 IU/day | 2.0% (11/546) |
| Vitamin E 400 IU/day | 0.6% (3/489) |
| Placebo | 4.2% (41/967) |
In biochemistry, vitamin E is a "generic descriptor for all tocopherols and tocotrienols that exhibit alpha-tocopherol activity. by virtue of the phenolic hydrogen on the 2h-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of isoprenoids."[2]
References
- ↑ Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (March 1996). "Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)". Lancet 347 (9004): 781–6. DOI:10.1016/S0140-6736(96)90866-1. PMID 8622332. Research Blogging.
- ↑ Anonymous (2024), Vitamin E (English). Medical Subject Headings. U.S. National Library of Medicine.